Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses

OMICS A Journal of Integrative Biology

Volumn 18, Issue 12, 2014, Pages 778-791

  Coumans, Joëlle V F ^a   Gau, David ^b   Poljak, Anne ^c,d   Wasinger, Valerie ^c,d   Roy, Partha ^b   Moens, Pierre D J ^a  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; BIOLOGICAL MARKER; PROFILIN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST METASTASIS; CANCER CELL; CANCER GROWTH; CANCER MORTALITY; CANCER SCREENING; CANCER SUSCEPTIBILITY; CELL CULTURE; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INDUSTRIALIZATION; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEOMICS; TREATMENT RESPONSE; BREAST TUMOR; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MASS SPECTROMETRY; PROFILINS; PROTEOMICS;

EID: 84919395698     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2014.0075     Document Type: Article

References (87)

1. Aghdasi B, Ye K, Resnick A, et al. (2001). FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle. Proc Natl Acad Sci USA 98, 2425-2430.
2. Aizawa H, Sutoh K, and Yahara I. (1996). Overexpression of cofilin stimulates bundling of actin filaments, membrane ruffling, and cell movement in Dictyostelium. J Cell Biol 132, 335-344.
3. Arner ES. (2009). Focus on mammalian thioredoxin reduc-tases-Important selenoproteins with versatile functions. Biochim Biophys Acta 1790, 495-526.
4. Arner ES, and Holmgren A. (2006). The thioredoxin system in cancer. Semin Cancer Biol 16, 420-426.
5. Bae YH, Ding Z, Das T, Wells A, Gertler F, and Roy P. (2010). Profilin1 regulates PI(3, 4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc Natl Acad Sci USA 107, 21547-21552.
6. Bae YH, Ding Z, Zou L, Wells A, Gertler F, and Roy P. (2009). Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins. J Cell Physiol 219, 354-364.
7. Baldassarre M, Razinia Z, Burande CF, Lamsoul I, Lutz PG, and Calderwood DA. (2009). Filamins regulate cell spreading and initiation of cell migration. PLoS One 4, e7830.
8. Bao L, Odell AF, Stephen SL, Wheatcroft SB, Walker JH, and Ponnambalam S. (2012). The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence. FEBS J 279, 4576-4588.
9. Baum N, Schiene-Fischer C, Frost M, et al. (2009). The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis. Oncogene 28, 3915-3925.
10. Belletti B, and Baldassarre G. (2011). Stathmin: A protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 15, 1249-1266.
11. Cadenas C, Franckenstein D, Schmidt M, et al. (2010). Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer. Breast Cancer Res 12, R44.
12. Cai L, Makhov AM, and Bear JE. (2007a). F-actin binding is essential for coronin 1B function in vivo. J Cell Sci 120, 1779-1790.
13. Cai L, Marshall TW, Uetrecht AC, Schafer DA, and Bear JE. (2007b). Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. Cell 128, 915-929.
14. Calderwood SK, Khaleque MA, Sawyer DB, and Ciocca DR. (2006). Heat shock proteins in cancer: Chaperones of tu-morigenesis. Trends Biochem Sci 31, 164-172.
15. Cha MK, Suh KH, and Kim IH. (2009). Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res 28, 93.
16. Chua BT, Volbracht C, Tan KO, Li R, Yu VC, and Li P. (2003). Mitochondrial translocation of cofilin is an early step in ap-optosis induction. Nat Cell Biol 5, 1083-1089.
17. Coumans JV, Gau D, Poljak A, Wasinger V, Roy P, and Moens P. (2014). Green fluorescent protein expression triggers pro-teome changes in breast cancer cells. Exp Cell Res 320, 33-45.
18. Coumans JV, Harvey J, Backhouse D, et al. (2011). Proteomic assessment of host-associated microevolution in the fungus Thielaviopsis basicola. Environ Microbiol 13, 576-588.
19. Coumans JV, Poljak A, Raftery MJ, Backhouse D, and Pereg-Gerk L. (2009). Analysis of cotton (Gossypium hirsutum) root proteomes during a compatible interaction with the black root rot fungus Thielaviopsis basicola. Proteomics 9, 335-349.
20. Ding Z, Joy M, Bhargava R, et al. (2014). Profilin-1 down-regulation has contrasting effects on early vs late steps of breast cancer metastasis. Oncogene 33, 2065-2074.
21. Evan GI, and Vousden KH., (2001). Proliferation, cell cycle and apoptosis in cancer. Nature 411, 342-348.
22. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, and Parkin DM. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893-2917.
23. Fingerle-Rowson G, Petrenko O, Metz CN, et al. (2003). The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100, 9354-9359.
24. Franceschini A, Szklarczyk D, Frankild S, et al. (2013). STRING v9.1: Protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41, D808-815.
25. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, and Kroemer G. (2006). Heat shock proteins 27 and 70: Anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5, 2592-2601.
26. Grisendi S, Mecucci C, Falini B, and Pandolfi PP. (2006). Nucleophosmin and cancer. Nat Rev Cancer 6, 493-505.
27. Gronborg M, Kristiansen TZ, Iwahori A, et al. (2006). Bio-marker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 5, 157-171.
28. Grunewald TG, Kammerer U, Schulze E, Schindler D, Honig A, Zimmer M, and Butt E. (2006). Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp Cell Res 312, 974-982.
29. Guo Z, He Y, Wang S, Zhang A, Zhao P, Gao C, and Cao B. (2011). Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells. Oncol Rep 26, 511-517.
30. Hao J, Wang K, Yue Y, et al. (2012). Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells. Mol Cell Biochem 359, 323-332.
31. Hartwig JH, Chambers KA, Hopcia KL, and Kwiatkowski DJ. (1989). Association of profilin with filament-free regions of human leukocyte and platelet membranes and reversible membrane binding during platelet activation. J Cell Biol 109, 1571-1579.
32. Hsu DK, Yang RY, and Liu FT. (2006). Galectins in apoptosis. Methods Enzymol 417, 256-273.
33. Huang DW, Sherman BT, and Lempicki RA. (2009a). Bioinfor-matics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37, 1-13.
34. Huang DW, Sherman BT, and Lempicki RA. (2009b). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57.
35. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, and Beach DH. (1999). A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 190, 1375-1382.
36. Imai K, Ichibangase T, Saitoh R, and Hoshikawa Y. (2008). A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry. Biomed Chromatogr 22, 1304-1314.
37. Janke J, Schluter K, Jandrig B, et al. (2000). Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med 191, 1675-1686.
38. Jego G, Hazoume A, Seigneuric R, and Garrido C. (2013). Targeting heat shock proteins in cancer. Cancer Lett 332, 275-285.
39. Jung H, Kim T, Chae HZ, Kim KT, and Ha H. (2001). Regulation of macrophage migration inhibitory factor and thiol-specific antioxidant protein PAG by direct interaction. J Biol Chem 276, 15504-15510.
40. Kang Y, Lee DC, Han J, et al. (2007). NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling. Biochem Biophys Res Commun 359, 76-82.
41. Klamt F, Zdanov S, Levine RL, et al. (2009). Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat Cell Biol 11, 1241-1246.
42. Kleemann R, Hausser A, Geiger G, et al. (2000). Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408, 211-216.
43. Korwar AM, Bhonsle HS, Ghole VS, Gawai KR, Koppikar CB, and Kulkarni MJ. (2013). Proteomic profiling and inter-actome analysis of ER-positive/HER2/neu negative invasive ductal carcinoma of the breast: Towards proteomics bio-markers. OMICS 17, 27-40.
44. Lahm H, Andre S, Hoeflich A, et al. (2001). Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127, 375-386.
45. Lam L, Aktary Z, Bishay M, et al. (2012). Regulation of sub-cellular distribution and oncogenic potential of nucleo-phosmin by plakoglobin. Oncogenesis 1, e4.
46. Lanneau D, Brunet M, Frisan E, Solary E, Fontenay M, and Garrido C. (2008). Heat shock proteins: Essential proteins for apoptosis regulation. J Cell Mol Med 12, 743-761.
47. Lee J. (2010). Role of cyclophilin a during oncogenesis. Arch Pharm Res 33, 181-187.
48. Lee SP, Hwang YS, Kim YJ, Kwon KS, Kim HJ, Kim K, and Chae HZ. (2001). Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem 276, 29826-29832.
49. Lee YJ, Mazzatti DJ, Yun Z, and Keng PC. (2005). Inhibition of invasiveness of human lung cancer cell line H1299 by over-expression of cofilin. Cell Biol Int 29, 877-883.
50. Li Z, and Li Z. (2012). Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks. Biochim Biophys Acta 1826, 13-22.
51. Li Z, Zhao J, Du Y, et al. (2008). Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci USA 105, 162-167.
52. Lim H, Eng J, Yates JR, 3rd, et al. (2003). Identification of 2D-gel proteins: A comparison of MALDI/TOF peptide mass mapping to mu LC-ESI tandem mass spectrometry. J Am Soc Mass Spectrom 14, 957-970.
53. McDermott WG, Boissan M, Lacombe ML, Steeg PS, and Horak CE. (2008). Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clin Exp Metastasis 25, 131-138.
54. McKiernan E, McDermott EW, Evoy D, Crown J, and Duffy MJ. (2011). The role of S100 genes in breast cancer progression. Tumor Biol 32, 441-450.
55. Minamida S, Iwamura M, Kodera Y, et al. (2011). Profilin 1 overexpression in renal cell carcinoma. Int J Urol 18, 63-71.
56. Miyamoto M, Iwashita S, Yamaguchi S, and Ono Y. (2009). Role of nm23 in the regulation of cell shape and migration via Rho family GTPase signals. Mol Cell Biochem 329, 175-179.
57. Moens PD, and Bagatolli LA. (2007). Profilin binding to sub-micellar concentrations of phosphatidylinositol (4, 5) bi-sphosphate and phosphatidylinositol (3, 4, 5) trisphosphate. Biochim Biophys Acta 1768, 439-449.
58. Mouneimne G, DesMarais V, Sidani M, et al. (2006). Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr Biol 16, 2193-2205.
59. Mouneimne G, Hansen SD, Selfors LM, et al. (2012). Differential remodeling of actin cytoskeleton architecture by pro-filin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell 22, 615-630.
60. Neuhoff V, Arold N, Taube D, and Ehrhardt W. (1988). Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9, 255-262.
61. Nguyen MT, Lue H, Kleemann R, et al. (2003). The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 170, 3337-3347.
62. Nurnberg A, Kitzing T, and Grosse R. (2011). Nucleating actin for invasion. Nat Rev Cancer 11, 177-187.
63. Oien KA, Vass JK, Downie I, Fullarton G, and Keith WN. (2003). Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene 22, 4287-4300.
64. Rana MK, and Worthylake RA. (2012). Novel mechanism for negatively regulating Rho-kinase (ROCK) signaling through Coronin1B protein in neuregulin 1 (NRG-1)-induced tumor cell motility. J Biol Chem 287, 21836-21845.
65. Riento K, and Ridley AJ. (2003). Rocks: Multifunctional ki-nases in cell behaviour. Nat Rev Mol Cell Biol 4, 446-456.
66. Rivera Rosado LA, Rodriguez-Canales J, and Zhang B. (2011). Association of D4-GDI expression with breast cancer progression. Cancer Biomark 10, 163-173.
67. Ross PL, Huang YN, Marchese JN, et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Pro-teomics 3, 1154-1169.
68. Roy P, and Jacobson K. (2004). Overexpression of profilin reduces the migration of invasive breast cancer cells. Cell Motil Cytoskeleton 57, 84-95.
69. Sacchetti A, Cappetti V, Marra P, Dell'Arciprete R, El Sewedy T, Crescenzi C, and Alberti S. (2001). Green fluorescent protein variants fold differentially in prokaryotic and eu-karyotic cells. J Cell Biochem Suppl Suppl 36, 117-128.
70. Sakaguchi M, Miyazaki M, Inoue Y, et al. (2000). Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J Cell Biol 149, 1193-1206.
71. Santamaria-Kisiel L, Rintala-Dempsey AC, and Shaw GS. (2006). Calcium-dependent and-independent interactions of the S100 protein family. Biochem J 396, 201-214.
72. Scott K, and Weinberg C. (2004). Galectin-1: A bifunctional regulator of cellular proliferation. Glycoconj J 19, 467-477.
73. Sullivan RP, Mortimer G, and Muircheartaigh IO. (1993). Cell proliferation in breast tumors: Analysis of histological parameters Ki67 and PCNA expression. Ir J Med Sci 162, 343-347.
74. Verjans E, Noetzel E, Bektas N, et al. (2009). Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer 9, 230.
75. Wang W, Eddy R, and Condeelis J. (2007). The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7, 429-440.
76. Wells V, Davies D, and Mallucci L. (1999). Cell cycle arrest and induction of apoptosis by beta galactoside binding protein (beta GBP) in human mammary cancer cells. A potential new approach to cancer control. Eur J Cancer 35, 978-983.
77. Witke W. (2004). The role of profilin complexes in cell mo-tility and other cellular processes. Trends Cell Biol 14, 461-469.
78. Wu N, Zhang W, Yang Y, et al. (2006). Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepato-carcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 6, 6095-6106.
79. Xu Y, Bismar TA, Su J, et al. (2010). Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion. J Exp Med 207, 2421-2437.
80. Yao W, Cai X, Liu C, et al. (2013). Profilin 1 potentiates ap-optosis induced by staurosporine in cancer cells. Curr Mol Med 13, 417-428.
81. Yao W, Yu X, Fang Z, et al. (2012). Profilin1 facilitates staurosporine-triggered apoptosis by stabilizing the integrin beta1-actin complex in breast cancer cells. J Cell Mol Med 16, 824-835.
82. Yap CT, Simpson TI, Pratt T, Price DJ, and Maciver SK. (2005). The motility of glioblastoma tumor cells is modulated by intracellular cofilin expression in a concentration-dependent manner. Cell Motil Cytoskeleton 60, 153-165.
83. Yoo MH, Xu XM, Carlson BA, Patterson AD, Gladyshev VN, and Hatfield DL. (2007). Targeting thioredoxin reductase 1 reduction in cancer cells inhibits self-sufficient growth and DNA replication. PLoS One 2, e1112.
84. Yung BY. (2007). Oncogenic role of nucleophosmin/B23. Chang Gung Med J 30, 285-293.
85. Zang L, Palmer Toy D, Hancock WS, Sgroi DC, and Karger BL. (2004). Proteomic analysis of ductal carcinoma of the breast using laser capture microdissection, LC-MS, and 16O/18O isotopic labeling. J Proteome Res 3, 604-612.
86. Zou L, Ding Z, and Roy P. (2010). Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation. J Cell Physiol 223, 623-629.
87. Zou L, Jaramillo M, Whaley D, Wells A, Panchapakesa V, Das T, and Roy P. (2007). Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer 97, 1361-1371.